Pharmaceuticals Advocate General in C 456/24 Halozyme: The MA has the final say on what constitutes an “active ingredient”A substance expressly designated in the marketing authorisation as an excipient cannot be regarded as an active ingredient for SPC purposes, according to AG EmiliouRead More 23Apr2026 Neurim in the mirrorEurope’s highest court is asked yet again to reconsider its approach to SPCs for new therapeutic usesRead More 05Feb2026 How ‘Boehringer’ sets preliminary relief threshold for genericsA UPC Court of Appeal decision establishes a new benchmark for what constitutes imminent infringement in pharmaceutical patent litigation, particularly regarding generics’ pre-launch preparationsRead More 20Oct2025 Legal 500 2026Carpmaels secures new category and individual rankingsRead More 01Oct2025 Lexology Index: IP 202515 partners recognised in this year’s editionRead More 27Aug2025 Council adopts position on EU pharma packageMajor changes to the EU’s pharmaceutical regime, including to regulatory exclusivity periods, are now one step closer.Read More 03Jul2025 Financial Times: Europe’s Leading Patent Law Firms 2025Carpmaels & Ransford retains top tier ranking for Chemistry & PharmacyRead More 12Jun2025 High Court rules on patents for algal omega-3 oilsHealth and nutrition specialist DSM successfully defends a patent protecting its algal processing technology for DHA omega-3 oils against a nutraceuticals competitorRead More 02Apr2025 EPO’s Enlarged Board of Appeal holds oral proceedings for referral G 1/23The Board heard all parties but did not provide any new insights on the points it considers important for its deliberationsRead More 13Mar2025 The UK’s approach for defining the “active ingredient” in an SPCHigh Court weighs in on the application of Forsgren to Halozyme’s Herceptin Hylecta® and MabThera® GB SPCsRead More 17Dec20241234…9> Type Firm News Insights PodcastsServiceProtectDealDisputeSectorHealthcare+Energy+Life SciencesChemistryMaterialsEngineeringTechCreativeArchive2026MayAprilMarchFebruaryJanuary2025DecemberNovemberOctoberSeptemberAugustJulyJuneAprilMarchFebruaryJanuary2024DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2023DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2022DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2021DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2020DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2019DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2018DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2017DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2016DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2015DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2014DecemberNovemberOctoberAugustJulyJuneMayAprilMarchFebruaryJanuary2013DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchJanuary2012NovemberJulyJuneMayAprilFebruaryJanuary
